Tregalizumab (Synonyms: BT-061) |
| Catalog No.GC70057 |
Tregalizumab es un anticuerpo monoclonal humanizado contra CD4 humano (tipo IgG1) que puede activar selectivamente las propiedades inhibitorias de las células T reguladoras (Tregs) in vitro. Tregalizumab se puede utilizar en la investigación de enfermedades autoinmunitarias (causadas por una deficiencia en la actividad de Tregs) y alergias.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1207446-68-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Tregalizumab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Tregalizumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *